High Negative Predictive Value Models for Clinical Rule-Out

You are reading version 1 of this direction, frozen 2026-10-04. The latest version is version 2.

Version 1 of 2150 papers167 conceptsfrozen 2026-10-04

In clinical medicine, the cost of a "false negative"—missing a patient who is actually sick—is often much higher than the cost of a "false positive." Consequently, healthcare systems are traditionally biased toward over-testing and over-treatment. However, this bias leads to overwhelmed intensive care units, antibiotic resistance, and unnecessary invasive procedures.

A growing body of research suggests that machine learning’s greatest contribution to medicine may not be its ability to "rule in" a diagnosis, but its ability to "rule out" risk with near-certainty. By optimizing for High Negative Predictive Value (NPV), these models act as clinical gatekeepers, identifying the "stable majority" who can safely bypass intensive interventions.

The Intuition of the Gatekeeper

To understand why NPV is the critical metric, consider a hospital during a pandemic surge. If a model has a high sensitivity and a high NPV, a "negative" result is incredibly reliable. If the model says a patient is low-risk, the clinician can be 98–100% certain they will not deteriorate.

This allows for a fundamental shift in resource management. Instead of monitoring everyone poorly, clinicians can monitor a small, high-risk subset intensely. Nestoras Mathioudakis and colleagues demonstrated this with insulin-induced hypoglycemia: by identifying patients who are definitively not at risk, medical staff can reduce unnecessary bedside glucose checks and focus on those truly in danger Mathioudakis et al. (2018).

Triaging Under Pressure

The utility of high-NPV models is most visible during resource crises. During the COVID-19 pandemic, researchers like Connor Davis and Aatish Patel developed frameworks to predict mortality and ICU needs at the moment of admission.

The goal wasn't just to find the sickest patients, but to confidently identify those who could be safely managed in lower-acuity settings. Maarten C. Ottenhoff showed that these models could outperform simple age-based triage, providing an objective way to "rule out" the need for intensive care beds Ottenhoff et al. (2021). Similarly, Maria Elena Laino used a point-based system to categorize patients, ensuring that stable cases did not clog critical care pipelines Laino et al. (2022).

Stewardship and the Prevention of Over-Treatment

Beyond emergency triage, high-NPV models serve as a defense against the side effects of modern medicine, such as antibiotic resistance and radiation exposure.

  • Antibiotic Stewardship: In neonatal care, Pak Cheung Ng developed a biomarker score with a 100% NPV for sepsis, allowing doctors to safely withhold antibiotics in 60% of symptomatic but uninfected infants Ng et al. (2010). In the ER, Martin J. Gill and Masayuki Nigo have applied similar logic to UTIs and MRSA, using EHR data to "rule out" the need for broad-spectrum drugs Nigo et al. (2024).
  • Radiation and Toxicity: For adolescent scoliosis, Teng Zhang developed ScolioNet, which uses smartphone photos to rule out severe spinal curves, sparing children from repeated X-ray radiation Zhang et al. (2022). In oncology, Xiaowen Feng and Edwin Wang identified gene signatures that predict chemotherapy non-responders with 94% precision, preventing patients from enduring toxic treatments that won't work Feng & Wang (2019).

Virtualizing the Invasive

Perhaps the most transformative application is the "virtualization" of invasive diagnostic procedures. In cardiology, determining if a coronary artery narrowing is actually blocking blood flow usually requires an invasive pressure-wire test (FFR).

New models by Catarina Oliveira and Xiaolu Xi use deep learning and fluid simulations to calculate these values from standard images. With NPVs reaching 90–100%, these "virtual FFR" tools act as a safe filter: if the AI says the lesion isn't significant, the patient can skip the catheterization lab entirely Oliveira et al. (2025).

Scaling Specialist Expertise

Finally, high-NPV models address the "bottleneck" of specialist review. In screening for retinopathy of prematurity, Travis K. Redd showed that AI can reliably identify healthy retinas, allowing experts to focus only on the high-risk cases Redd et al. (2018). Similar "force multipliers" have been developed for gastric dysplasia by Zhongyue Shi and bone metastases by Yun Zhang, where the AI filters out the negative samples so pathologists and radiologists can prioritize the most complex cases Zhang et al. (2025).

By shifting the focus from "finding the needle" to "confidently removing the haystack," these researchers are building a more efficient, safer, and more sustainable healthcare system.

Papers in this version

Showing 60 of 150 papers.

History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 138 papers
  2. Version 1 · 2026-10-04 · 150 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_negative_predictive_value_optimization_526b19dc,
  title = {negative predictive value optimization},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/negative-predictive-value-optimization/rdr_526b19dc97d34632b26792c981df0c6a},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}

This exact version (version 1, frozen text):

@misc{lacuna_high_negative_predictive_value_models_fo_526b19dc_v1,
  title = {High Negative Predictive Value Models for Clinical Rule-Out},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/high-negative-predictive-value-models-for-clinical-rule-out/rdr_526b19dc97d34632b26792c981df0c6a/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}